Influence of diabetes mellitus interactions with cardiovascular risk factors on post-myocardial infarction heart failure hospitalizations

被引:4
作者
Yandrapalli, Srikanth [1 ]
Malik, Aaqib H. [2 ,3 ]
Namrata, Fnu [2 ,3 ]
Pemmasani, Gayatri [4 ]
Bandyopadhyay, Dhrubajyoti [2 ,3 ]
Vallabhajosyula, Saraschandra [5 ]
Aronow, Wilbert S. [2 ,3 ]
Frishman, William H. [3 ,6 ]
Jain, Diwakar [2 ,3 ]
Cooper, Howard A. [2 ,3 ]
Panza, Julio A. [2 ,3 ]
机构
[1] Harvard Med Sch, Div Cardiol, Massachusetts Gen Hosp, Boston, MA 02114 USA
[2] Westchester Med Ctr, Dept Cardiol, Valhalla, NY USA
[3] New York Med Coll, Valhalla, NY 10595 USA
[4] SUNY Upstate Med Univ, Dept Med, Syracuse, NY 13210 USA
[5] Wake Forest Univ, Bowman Gray Sch Med, Sect Cardiol, Winston Salem, NC USA
[6] Westchester Med Ctr, Dept Med, Valhalla, NY USA
关键词
Acute myocardial infarction; Diabetes mellitus; Heart failure; Risk factors; Outcomes; NONINSULIN ANTIHYPERGLYCEMIC DRUGS; MYOCARDIAL-INFARCTION; OUTCOMES; IMPACT; MORTALITY; BENEFITS; INSULIN; SAFETY;
D O I
10.1016/j.ijcard.2021.11.086
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: There is a paucity of information regarding how cardiovascular risk factors (RF) modulate the impact of diabetes mellitus (DM) on the heart failure hospitalization (HFH) risk following an acute myocardial infarction (AMI). Methods: Adult survivors of an AMI were retrospectively identified from the 2014 US Nationwide Readmissions Database. The impact of DM on the risk for a 6-month HFH was studied in subgroups of RFs using multivariable logistic regression to adjust for baseline risk differences. Individual interactions of DM with RFs were tested. Results: Of 237,549 AMI survivors, 37.2% patients had DM. Primary outcome occurred in 12,934 patients (5.4%), at a 106% higher rate in DM patients (7.9% vs 4.0%, p < 0.001), which was attenuated to a 45% higher adjusted risk. Higher HFH risk in DM patients was consistent across subgroups and significant interactions were present between DM and other RFs. The increased HFH risk with DM was more pronounced in patients without certain HF RFs compared with those with these RFs [age < 65: OR for DM 1.84 (1.58-2.13) vs age >= 65: OR 1.34 (1.24-1.45); HF absent during index AMI: OR for DM 1.87 (1.66-2.10) vs HF present: OR 1.24 (1.14-1.34); atrial fibrillation absent: OR for DM 1.57 (1.46-1.68) vs present: OR 1.19 (1.06-1.33); Pinteraction < 0.001 for all]. Similar results were noted for hypertension and chronic kidney disease. Conclusions: AMI survivors with DM had a higher risk of 6-month HFHs. The impact of DM on the increased HFH risk was more pronounced in patients without certain RFs suggesting that more aggressive preventive strategies related to DM and HF are needed in these subgroups to prevent or delay the onset of HFHs.
引用
收藏
页码:140 / 146
页数:7
相关论文
共 22 条
[1]  
[Anonymous], 2005, APPL LOGISTIC REGRES, P143, DOI [10.1002/0471722146.ch5, DOI 10.1002/0471722146.CH5]
[2]   Influence of diabetes mellitus on heart failure risk and outcome [J].
Bauters, Christophe ;
Lamblin, Nicolas ;
Mc Fadden, Eugene P. ;
Van Belle, Eric ;
Millaire, Alain ;
de Groote, Pascal .
CARDIOVASCULAR DIABETOLOGY, 2003, 2 (1)
[3]   Impact of Diabetes Mellitus on Hospitalization for Heart Failure, Cardiovascular Events, and Death Outcomes at 4 Years From the Reduction of Atherothrombosis for Continued Health (REACH) Registry [J].
Cavender, Matthew A. ;
Steg, Ph Gabriel ;
Smith, Sidney C., Jr. ;
Eagle, Kim ;
Ohman, E. Magnus ;
Goto, Shinya ;
Kuder, Julia ;
Im, Kyungah ;
Wilson, Peter W. F. ;
Bhatt, Deepak L. .
CIRCULATION, 2015, 132 (10) :923-931
[4]   Sex-Related Differences in Heart Failure After ST-Segment Elevation Myocardial Infarction [J].
Cenko, Edina ;
van der Schaar, Mihaela ;
Yoon, Jinsung ;
Manfrini, Olivia ;
Vasiljevic, Zorana ;
Vavlukis, Marija ;
Kedev, Sasko ;
Milicic, Davor ;
Badimon, Lina ;
Bugiardini, Raffaele .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 74 (19) :2379-2389
[5]   Improving care for patients with acute heart failure: before, during and after hospitalization [J].
Cowie, Martin R. ;
Anker, Stefan D. ;
Cleland, John G. F. ;
Felker, G. Michael ;
Filippatos, Gerasimos ;
Jaarsma, Tiny ;
Jourdain, Patrick ;
Knight, Eve ;
Massie, Barry ;
Ponikowski, Piotr ;
Lopez-Sendon, Jose .
ESC HEART FAILURE, 2014, 1 (02) :110-145
[6]  
Ezekowitz JA, 2009, J AM COLL CARDIOL, V53, P13, DOI 10.1016/j.jacc.2008.08.067
[7]   Correlates and prognostic impact of new-onset heart failure after ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention: insights from the INFUSE-AMI trial [J].
Giustino, Gennaro ;
Redfors, Bjorn ;
Brener, Sorin J. ;
Kirtane, Ajay J. ;
Genereux, Philippe ;
Maehara, Akiko ;
Dudek, Dariusz ;
Neunteufl, Thomas ;
Metzger, D. Christopher ;
Crowley, Aaron ;
Mehran, Roxana ;
Gibson, C. Michael ;
Stone, Gregg W. .
EUROPEAN HEART JOURNAL-ACUTE CARDIOVASCULAR CARE, 2018, 7 (04) :339-347
[8]   Heart Failure in Type 2 Diabetes Mellitus Impact of Glucose-Lowering Agents, Heart Failure Therapies, and Novel Therapeutic Strategies [J].
Kenny, Helena C. ;
Abel, E. Dale .
CIRCULATION RESEARCH, 2019, 124 (01) :121-141
[9]   Predictors of late development of heart failure in stable survivors of myocardial infarction - The CARE study [J].
Lewis, EF ;
Moye, LA ;
Rouleau, JL ;
Sacks, FM ;
Arnold, JMO ;
Warnica, JW ;
Flaker, GC ;
Braunwald, E ;
Pfeffer, MA .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 42 (08) :1446-1453
[10]  
Malmberg K, 1996, EUR HEART J, V17, P1337